$CVRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corindus Vascular Robotics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Corindus Vascular Robotics, Inc.. Get notifications about new insider transactions in Corindus Vascular Robotics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 23 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.99 | 15,000 | 14,804 | 193,909 | 178.9 K to 193.9 K (+8.38 %) |
Aug 23 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.99 | 15,000 | 14,913 | 0 | -15,000 to 0 (-100.00 %) |
Aug 23 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.99 | 15,000 | 14,804 | 193,909 | 178.9 K to 193.9 K (+8.38 %) |
Aug 14 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.95 | 10,500 | 9,975 | 178,909 | 168.4 K to 178.9 K (+6.23 %) |
Aug 14 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.96 | 20,500 | 19,760 | 168,408 | 147.9 K to 168.4 K (+13.86 %) |
Aug 14 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.95 | 10,500 | 9,975 | 178,909 | 168.4 K to 178.9 K (+6.23 %) |
Aug 14 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.96 | 20,500 | 19,760 | 168,408 | 147.9 K to 168.4 K (+13.86 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,818 | 61.5 K to 65.8 K (+6.94 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.17 | 5,128 | 6,000 | 147,909 | 142.8 K to 147.9 K (+3.59 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,032 | 60.8 K to 65 K (+7.03 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,818 | 61.5 K to 65.8 K (+6.94 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.17 | 5,128 | 6,000 | 147,909 | 142.8 K to 147.9 K (+3.59 %) |
Jul 11 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.17 | 4,273 | 4,999 | 65,032 | 60.8 K to 65 K (+7.03 %) |
Jun 19 2018 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | A | 0.89 | 500,000 | 445,000 | 500,000 | |
Jun 04 2018 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Grant | A | 0.75 | 53,326 | 40,000 | 62,500 | 9.2 K to 62.5 K (+581.27 %) |
Jun 04 2018 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 0.75 | 5,183,322 | 3,888,010 | 5,183,322 | |
Jun 04 2018 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Grant | A | 0.75 | 53,326 | 40,000 | 87,500 | 34.2 K to 87.5 K (+156.04 %) |
Jun 04 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 0.75 | 53,326 | 40,000 | 61,545 | 8.2 K to 61.5 K (+648.81 %) |
Jun 04 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 0.75 | 53,326 | 40,000 | 142,781 | 89.5 K to 142.8 K (+59.61 %) |
Jun 04 2018 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Grant | A | 0.75 | 53,326 | 40,000 | 62,500 | 9.2 K to 62.5 K (+581.27 %) |
Jun 04 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 0.75 | 53,326 | 40,000 | 60,759 | 7.4 K to 60.8 K (+717.42 %) |
May 25 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.77 | 6,500 | 5,003 | 89,455 | 83 K to 89.5 K (+7.84 %) |
May 25 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.80 | 10,000 | 8,009 | 82,955 | 73 K to 83 K (+13.71 %) |
May 18 2018 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Buy | P | 0.80 | 15,000 | 12,000 | 34,174 | 19.2 K to 34.2 K (+78.23 %) |
May 18 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.81 | 6,000 | 4,859 | 72,955 | 67 K to 73 K (+8.96 %) |
Apr 10 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.36 | 653 | 888 | 7,433 | 6.8 K to 7.4 K (+9.63 %) |
Apr 10 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.36 | 4,687 | 6,374 | 66,955 | 62.3 K to 67 K (+7.53 %) |
Mar 20 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 1.40 | 350,000 | 490,000 | 350,000 | |
Mar 20 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 1.25 | 40,000 | 50,000 | 40,000 | |
Mar 20 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 0.00 | 6,780 | 0 | 6,780 | 0 to 6.8 K |
Mar 15 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 0.00 | 8,219 | 0 | 8,219 | 0 to 8.2 K |
Mar 15 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 0.00 | 8,219 | 0 | 8,219 | 0 to 8.2 K |
Feb 06 2018 | CVRS | Corindus Vascular ... | Lemaster Stephen Jeffrey | Chief Commercial Of ... | Option Exercise | A | 1.05 | 40,000 | 42,000 | 40,000 | |
Feb 06 2018 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | A | 1.05 | 110,000 | 115,500 | 110,000 | |
Dec 19 2017 | CVRS | Corindus Vascular ... | BAKEWELL JOHN K | Director | Option Exercise | A | 0.00 | 32,072 | 0 | 32,072 | |
Dec 19 2017 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Option Exercise | A | 0.00 | 9,174 | 0 | 9,174 | |
Dec 19 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 0.00 | 9,174 | 0 | 9,174 | |
Dec 19 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.09 | 2,293 | 2,499 | 53,094 | 50.8 K to 53.1 K (+4.51 %) |
Dec 19 2017 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | A | 0.00 | 9,174 | 0 | 9,174 | |
Dec 19 2017 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | A | 0.00 | 9,174 | 0 | 9,174 | |
Nov 14 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.79 | 6,000 | 4,740 | 50,801 | 44.8 K to 50.8 K (+13.39 %) |
Nov 14 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.82 | 17,801 | 14,616 | 44,801 | 27 K to 44.8 K (+65.93 %) |
Nov 06 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 0.97 | 3,607 | 3,500 | 3,607 | |
Oct 13 2017 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | 10% Owner | Option Exercise | X | 1.06 | 4,728,191 | 5,011,882 | 0 | |
Oct 13 2017 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | 10% Owner | Sell | S | 1.50 | 3,334,586 | 5,011,883 | 26,358,858 | 29.7 M to 26.4 M (-11.23 %) |
Oct 13 2017 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | 10% Owner | Buy | X | 1.06 | 4,728,191 | 5,011,882 | 29,693,444 | 25 M to 29.7 M (+18.94 %) |
Jun 26 2017 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 0.71 | 297,335 | 209,621 | 297,335 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 1.85 | 5,566 | 10,297 | 5,566 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | A | 1.68 | 5,332 | 8,958 | 5,332 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
Jun 26 2017 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
May 19 2017 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 0.71 | 297,335 | 209,621 | 297,335 | |
Apr 10 2017 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | A | 1.17 | 100,000 | 117,000 | 100,000 | |
Mar 23 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.32 | 973 | 1,280 | 27,000 | 26 K to 27 K (+3.74 %) |
Mar 23 2017 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.30 | 26,027 | 33,874 | 26,027 | 0 to 26 K |
Mar 10 2017 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | 10% Owner | Buy | P | 0.66 | 7,557,436 | 5,000,000 | 24,965,253 | 17.4 M to 25 M (+43.41 %) |
Mar 02 2017 | CVRS | Corindus Vascular ... | Lightcap Jeffrey C | Director | Buy | P | 0.66 | 7,557,436 | 5,000,000 | 32,500,478 | 24.9 M to 32.5 M (+30.30 %) |
Mar 02 2017 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 0.66 | 7,557,436 | 5,000,000 | 15,409,537 | 7.9 M to 15.4 M (+96.25 %) |
Dec 05 2016 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 0.70 | 297,335 | 208,135 | 297,335 | |
Dec 05 2016 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 1.46 | 297,335 | 434,109 | 297,335 | |
Nov 28 2016 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Buy | P | 0.76 | 902 | 686 | 10,000 | 9.1 K to 10 K (+9.91 %) |
Nov 28 2016 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Buy | P | 0.76 | 9,098 | 6,914 | 9,098 | 0 to 9.1 K |
Oct 12 2016 | CVRS | Corindus Vascular ... | Lemaster Stephen Jeffrey | Chief Commercial Of ... | Option Exercise | A | 1.18 | 550,000 | 649,000 | 550,000 | |
Sep 29 2016 | CVRS | Corindus Vascular ... | WHITE DAVID RICHARD | Director | Option Exercise | A | 1.10 | 27,272 | 29,999 | 27,272 | |
Sep 29 2016 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | A | 1.10 | 27,272 | 29,999 | 27,272 | |
Sep 29 2016 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | A | 1.10 | 27,272 | 29,999 | 27,272 | |
Sep 29 2016 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Option Exercise | A | 1.10 | 27,272 | 29,999 | 27,272 | |
Jun 27 2016 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | A | 1.46 | 100,000 | 146,000 | 100,000 | |
Jun 27 2016 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | A | 1.46 | 35,000 | 51,100 | 35,000 | |
Mar 10 2016 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | A | 1.46 | 7,136,049 | 10,418,632 | 7,136,049 | |
Feb 08 2016 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | A | 2.03 | 98,522 | 200,000 | 98,522 | |
Jan 04 2016 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Buy | J | 0.00 | 3,663 | 0 | 78,669 | 75 K to 78.7 K (+4.88 %) |
Jan 04 2016 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Sell | J | 0.00 | 82,331 | 0 | 0 | 82.3 K to 0 (-100.00 %) |
Dec 21 2015 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Sell | J | 0.00 | 5,809,750 | 0 | 964,586 | 6.8 M to 964.6 K (-85.76 %) |
Dec 17 2015 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Option Exercise | M | 0.22 | 82,331 | 18,113 | 0 | |
Dec 17 2015 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Option Exercise | M | 0.22 | 75,006 | 16,501 | 0 | |
Dec 17 2015 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Buy | M | 0.22 | 82,331 | 18,113 | 82,331 | 0 to 82.3 K |
Dec 17 2015 | CVRS | Corindus Vascular ... | Bachrach Hillel | Director | Buy | M | 0.22 | 75,006 | 16,501 | 75,006 | 0 to 75 K |